Business Wire

Fishawack Group Acquires Healthcircle to Strengthen Creative Offering

Jaa

The Fishawack Group of Companies, one of the world’s largest independent medical communications organisations, has acquired Healthcircle Advertising Limited, a strategic brand communications agency with offices in London and Portugal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180709005905/en/

Top row: Dominic Miller, Fishawack COO, Gail Flockhart, Fishawack Managing Partner, Liz Maclaren, He ...

Top row: Dominic Miller, Fishawack COO, Gail Flockhart, Fishawack Managing Partner, Liz Maclaren, Healthcircle Creative Director, Dr. David Ingram, Healthcircle Managing Partner; Bottom row: Mike Taylor, Healthcircle Managing Director, Oliver Dennis, Fishawack CEO (Photo: Business Wire)

This acquisition is a major step in Fishawack’s plan to build a global strategic creative agency that can work alongside our medical communications business,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “We also acquired US-based Carling Communications in July last year. Carling needed critical mass in Europe and Healthcircle needed a US partner. This is a great match and positions us to deliver integrated creative and medcomms solutions for clients on a truly global scale.”

Mike Taylor, Managing Director of Healthcircle added, “We’ve been on the lookout for a partner to support our growth in the US whilst also providing us access to scientific and strategic talent. Healthcircle and Fishawack have already collaborated extensively and we’ve known and worked with many of the Carling team over our years in the business.”

Gail Flockhart, Group Managing Director at Fishawack said, “All agencies are collections of people with different talents. What makes us different is the investment we make in establishing real chemistry between teams so that collaboration is fun and triggers new ideas. We’re still at a size where we can make this meaningful.”

About the Fishawack Group

The Fishawack Group of Companies is one of the largest independent medical communications specialists, with offices in the UK (Knutsford, Oxford, and Brighton), the USA (Philadelphia, PA, and San Diego, CA), Switzerland (Basel), and India (Hyderabad).

For over 17 years, Fishawack has been partnering with global and regional pharmaceutical, biotechnology, and medical device clients to develop and deliver services in the fields of medical communications, scientific engagement, market access, strategic consultancy, and thought leader consultancy. For more detailed information about our services, please see the Fishawack Group website at www.fishawack.com.

We have built our reputation on excellence, creativity, and transparency.

About Healthcircle

Healthcircle is a full-service strategic brand communications agency. With extensive experience in direct-to-patient communications, creative digital solutions and creative medcomms, Healthcircle has consistently won awards for its surprising and innovative creative work. Healthcircle is headquartered in London, UK, with an office in Cascais, Portugal.

Healthcircle strongly believes that connecting strategy and creative is the key to brand success and has demonstrated the success of this approach on some of the largest brands in the global pharmaceutical marketplace during the last 10 years. More information is available at www.healthcircle-uk.com

Fishawack Group of Companies

www.fishawack.com
Twitter: @Fishawack
LinkedIn: Fishawack Group of Companies

Headquarters:

100–102 King Street, Knutsford, Cheshire, WA16 6HQ, UK
Tel: +44 1565 756600

Contact information

The Fishawack Group
Gail Flockhart
Group Managing Director
gail.flockhart@fishawack.com
or
Healthcircle Advertising Ltd
Mike Taylor
Managing Director
Mike.taylor@Healthcircle-uk.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme